Capricor Therapeutics Inc (CAPR)

[Volcano]

Our targeted delivery platform can carry therapeutic payloads that are produced via an exogenous process for loading certain types of payloads, which is similar to what most in our space are doing, or via an endogenous loading process for other types of payloads, including proteins.

This last approach relies on our proprietary technology, which allows for better consistency and preservation of the integrity of the cargo. We believe this positions Capricor to be able to attract potential partnerships and drive new therapeutic modalities.

The emerging exosomes platform will have potential applications in multiple domains, including vaccines, delivery of RNAs, including small interfering RNAs, and antisense molecules, as well as other payloads.

We have used our proprietary technology to develop an exosome-based vaccine with robust preclinical data. We plan on positioning this opportunity for partnering discussion.